Epidemiologic typing of Enterobacter sakazakii in two neonatal nosocomial outbreaks.
Two unrelated hospital outbreaks of Enterobacter sakazakii, involving meningitis, bacteremia, and colonization of neonates, were investigated. In each of these outbreaks, E. sakazakii was isolated from both patients and dried infant formula. In previous outbreaks, the source and mode of transmission of E. sakazakii in neonatal infections was not determined. In this study, we used a combination of typing methods (plasmid analysis, antibiograms, chromosomal restriction endonuclease analysis, ribotyping, and multilocus enzyme electrophoresis) to evaluate the isolates from each outbreak as to their relatedness. The typing results differed among outbreaks, but in each one, patient and formula isolates shared the same typing pattern. The only exceptions were disk antibiograms, which often varied among colonies selected from each of the isolates. Plasmid analysis, chromosomal restriction endonuclease analysis, ribotyping, and multilocus enzyme electrophoresis all were effective as epidemiological typing methods for E. sakazakii, especially when used in combination. By using this typing scheme, we have confirmed that E. sakazakii from intrinsically contaminated dried infant formula was the source of neonatal infection.
Clark
N C
NC
Antimicrobics Investigations Branch, Center for Infectious Diseases, U.S. Public Health Service, Atlanta, Georgia 30333.
Hill
B C
BC
O'Hara
C M
CM
Steingrimsson
O
O
Cooksey
R C
RC
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D003428:Cross Infection / Q000453:epidemiology* / Q000382:microbiology; D004269:DNA, Bacterial / Q000032:analysis; D004196:Disease Outbreaks; D004754:Enterobacter / Q000145:classification* / Q000187:drug effects / Q000201:enzymology / Q000235:genetics; D004756:Enterobacteriaceae Infections / Q000453:epidemiology* / Q000382:microbiology; D004798:Enzymes / Q000032:analysis; D005516:Food Microbiology; D006801:Humans; D007225:Infant Food; D007231:Infant, Newborn; D010957:Plasmids; D015183:Restriction Mapping
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004798:Enzymes